MedPath

Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation

Not Applicable
Completed
Conditions
Persistent Atrial Fibrillation
Interventions
Device: ThermoCoolSmartTouch ablation catheter, Biosense Webster
Registration Number
NCT01851525
Lead Sponsor
Southlake Regional Health Centre
Brief Summary

Catheter ablation has emerged as an effective therapy for atrial fibrillation (AF). However, achievement of complete\& durable isolation of the pulmonary veins (PVs) is challenging, primary limited both by operator experience and also the limits of currently available ablation technology. Direct contact force sensing (CFS) is a novel technology that may help to ensure adequate lesion delivery. CFS may also help to improve the safety profile of catheter ablation. The purpose of this study is to compare two strategies of wide antral PV isolation plus linear ablation for persistent AF:

1. guided by contact force sensing (CFS) OR

2. blinded to contact force sensing (CFS) - i.e. standard approach

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Contact Force Sensing (CFS) BlindedThermoCoolSmartTouch ablation catheter, Biosense WebsterContact Force Sensing (CFS) Blinded: Operator will be blinded to data provided by the integrated force sensor in the ablation catheter (ThermoCoolSmartTouch ablation catheter)
Contact Force Sensing (CFS) GuidedThermoCoolSmartTouch ablation catheter, Biosense WebsterContact Force Sensing (CFS) Guided: Operator will be guided by integrated force sensor in the ablation catheter (ThermoCoolSmartTouch ablation catheter)
Primary Outcome Measures
NameTimeMethod
Total cumulative radio frequency (RF) delivery time12 months

Total cumulative RF delivery time for all ablation procedures performed during the study period (12 mo)

Secondary Outcome Measures
NameTimeMethod
Reduction in atrial arrhythmia burden by >90%12 months
Incidence of repeat ablation procedures12 months
Freedom from AF or atrial arrhythmia >30 sec12 months

Freedom from AF or atrial arrhythmia \>30 sec at 12 months post-initial ablation

Ability to achieve PV isolation with a single ring of lesions around each PV6 hours

Ability to achieve PV isolation with a single ring of lesions around each PV

Incidence of conduction gaps around pulmonary veins12 months

Incidence of conduction gaps around pulmonary veins and correlation to force measures in those gaps

Ability to achieve linear ablation with complete conduction block on the first attempt6 hours

Ability to achieve linear ablation with complete conduction block on the first attempt

Number & location of conduction gaps after initial circumferential ablation lines6 hours

Number \& location of conduction gaps after initial circumferential ablation lines during first ablation procedure

Number & location of conduction gaps after initial linear ablation6 hours

Number \& location of conduction gaps after initial linear ablation during first ablation procedure

Time required for successful PV isolation12 months

Time required for successful PV isolation taking into consideration all ablation procedures

Total fast anatomical mapping (FAM) time12 months

Total FAM time taking into consideration all ablation procedures

Time required for successful linear ablation12 months

Time required for successful linear ablation taking into consideration all ablation procedures

FAM volume12 months

FAM volume of CFS vs non-CFS guided maps

Freedom from ablation-related major adverse events at 90 days post-ablation - specifically perforation, stroke/thromboembolism, esophageal injury, and symptomatic PV stenosis90 days

Freedom from ablation-related major adverse events at 90 days post-ablation - specifically perforation, stroke/thromboembolism, esophageal injury, and symptomatic PV stenosis

Freedom from atrial arrhythmia > 30 sec12 months

Freedom from atrial arrhythmia \> 30 sec at 12 months after one procedure

Freedom from atrial arrhythmia > 30 sec after one or two procedures12 months

Freedom from atrial arrhythmia \> 30 sec at 12 months after one or two procedures

Trial Locations

Locations (4)

Vancouver Island Cardiac Arrhythmia Clinic

🇨🇦

Victoria, British Columbia, Canada

Montreal Heart Institute

🇨🇦

Montreal, Quebec, Canada

Southlake Regional Health Centre

🇨🇦

Newmarket, Ontario, Canada

Laval University Cardiac and Pulmonary Institute

🇨🇦

Quebec City, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath